India's generic drugmaker Dr Reddy's Laboratories reported fourth-quarter profit above ex...
NA/PSAI drive earnings Higher working capital needs reduce free cash flow for the quarter ...
Result Synopsis Dr Reddys’ continues to benefit from Revlimid, potentially better tracti...
Nestle India reported a bigger-than-expected increase in its quarterly profit on Thursday, as it ...
The Indian Institute of Management (IIM) Raipur proudly hosted its 13th Annual Convocation Ceremo...
DRRD’s US business has sustained its strong momentum led by gRevlimid, ramp-up in base busi...
Dr. Reddy's Laboratories is currently trading at Rs. 6135.95, up by 88.35 points or 1.46% fro...
Dr. Reddy's Laboratories Ltd * DRREDDY has been in a steady uptrend from last more than 3 ...
Dr. Reddy's Laboratories Ltd Buy Dr. Reddy's Laboratories Ltd @ 6378-6382; Ta...
U.S. drugmaker Eli Lilly expects to launch Mounjaro, its blockbuster diabetes drug and wildly pop...
Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie,...
Dr. Reddy’s quarterly earnings were in-line with our expectations. Healthy performance on t...
Novartis India shares jumped more than 6 per cent on Monday after the parent company, Novartis AG...
Dr. Reddy's Laboratories is currently trading at Rs. 6259.85, up by 107.40 points or 1.75% fr...
Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter...
India's J B Chemicals and Pharmaceuticals reported its sixth straight quarter of profit...
India's Alembic Pharmaceuticals reported a bigger-than-expected third-quarter profit on Monda...
Indian drugmaker Torrent Pharmaceuticals reported a 30% rise in its pre-tax profit for the third-...
Pharma major Dr Reddy’s Laboratories on Tuesday reported a net profit of Rs 1,378.9 c...
The US generics market and branded markets have seen significant growth, with moderate raw materi...
Dr. Reddy's Laboratories is currently trading at Rs. 5828.15, up by 30.25 points or 0.52% fro...
Dr. Reddy's Laboratories Ltd * Pharma index trading at record highs and DRREDDY is expecte...
Shares of Indian drugmaker Dr. Reddy's Laboratories were down 5.8% on Monday after the U.S. F...
Dr. Reddy’s Laboratories is currently trading at Rs. 5805.25, up by 77.30 points or 1.35% f...
Life Insurance Corporation of India is currently trading at Rs. 683.85, up by 10.20 points or 1.5...
DRREDDY Ltd * We are witnessing decent traction in Pharma pack and Dr Reddy is excepted to wit...
Dr. Reddy's Laboratories is currently trading at Rs. 5538.60, up by 119.25 points or 2.20% fr...
Triggers & headwinds cancel out Result Synopsis Dr Reddys’ management alluded to ...
Niche products lead to superior margins Emerging markets and PSAI drag performance to some ext...
Dr. Reddy's Laboratories is currently trading at Rs. 5468.00, up by 16.65 points or 0.31% fro...
Indian biopharmaceutical company Biocon reported a smaller-than-expected quarterly profit on Frid...
Abbott India, the local unit of U.S. healthcare firm Abbott Laboratories, reported a 17.7% rise i...
The Indian market is resurging amid a drop in investors' anxiety as Nifty VIX contracts...
Pharma major Dr. Reddy’s Laboratories Ltd on Wednesday announced that the prestigious Scien...
India's Dr Reddy's Laboratories reported a bigger-than-expected rise in second-quarter pr...
The Nifty Realty and Nifty PSU Bank sectors both saw gains of 4 per cent and 2.08 per cent, respe...
Dr. Reddy's Laboratories is currently trading at Rs. 5614.85, up by 189.30 points or 3.49% from i...